Cerebrovascular risk in rheumatoid arthritis patients: insights from carotid artery atherosclerosis in the Paracelsus 10,000 study
Mathias Ausserwinkler(Paracelsus Medical University), Bernhard Wernly(Paracelsus Medical University), Jens Thiel(University of Freiburg), Bernhard Paulweber(Paracelsus Medical University), Maria Flamm(Paracelsus Medical University), Vanessa Frey(Paracelsus Medical University), Sophie Gensluckner(Paracelsus Medical University), Christian Datz(Paracelsus Medical University), Eugen Trinka(Paracelsus Medical University), Isabella Gostner(Paracelsus Medical University), H Neumann(Krankenhaus der Elisabethinen), Elmar Aigner, Patrick B. Langthaler(Paracelsus Medical University), Bernhard Iglseder(Paracelsus Medical University)
Cited by 17
Related Papers
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
|The Lancet|2019|1.2k
3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial
|The Lancet|2017|843
Genetic associations at 53 loci highlight cell types and biological pathways relevant for kidney function
|Nature Communications|2016|535
Lipid lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel
|Archives of Medical Science|2017|288
Lipid-lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel
|Nutrition Reviews|2017|286